Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,585.35
(
-0.59%
)
US TECH 100
23,566.40
(
-0.96%
)
Dow Jones
45,846.33
(
-0.82%
)
Brent Oil
107.10
(
0.49%
)
Bitcoin
69,376.87
(
-2.62%
)
News Focus
News Focus

Replies to post #11429 on Momenta Pharmaceuticals, Inc. (MNTA)

Replies to #11429 on Momenta Pharmaceuticals, Inc. (MNTA)
icon url

jbog

03/27/14 7:57 AM

#11430 RE: nu123 #11429

The PH3 trial had to be performed for European approvals so I think Synthon is simply trying to kill two birds with one stone.

I agree that the results make many of Teva's claims mute.